Aspira Pathlab & Diagnostics Ltd — Updates, 27-05-2025: Company Update

Aspira Pathlab & Diagnostics Limited has submitted its Annual Secretarial Compliance Report for the financial year ending March 31, 2025, confirming adherence to applicable SEBI regulations and secretarial standards. The company maintains updated policies, preserves records appropriately, and ensures timely disclosures. No director disqualifications, subsidiary-related issues, or regulatory non-compliances were noted. All related party transactions received proper approvals, and there were no actions taken against the company or its management by SEBI or stock exchanges. No resignation of statutory auditors occurred during the period. Overall, the company remains compliant with required corporate governance and disclosure norms, supporting transparent operations.